Hollywood, Florida
CNS clinical trials in Hollywood, FL
33 CNS studies are recruiting participants at sites in Hollywood as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Hollywood at a glance
- 33 studies are recruiting at a site in Hollywood.
- By phase: Phase 1 (2), Phase 2 (8), Phase 3 (21), Phase 4 (1), Observational (1).
- By sponsor: industry (30), university, hospital or other (3).
- By research area: Schizophrenia (15), Depression (11), Bipolar Disorder (4), Migraine (2), Multiple Sclerosis (1).
- Most recent update to one of these records: November 13, 2026.
Depression studies recruiting in Hollywood
Basic details from each study's public record (the 30 most recently updated of 33). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Study site
- The Medici Medical Research
- Registry record
- NCT07284667 · updated
E-Mindfulness Approaches for Living After Breast Cancer
- Phase 3
- Ages 18 to 50
- All sexes
- Sponsor
- NRG Oncology
- Study site
- UM Sylvester Comprehensive Cancer Center at Hollywood
- Registry record
- NCT06748222 · updated
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Encore Medical Research
- Registry record
- NCT07412756 · updated
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
- Observational
- From 18 months, up to 11 years
- All sexes
- Sponsor
- State University of New York at Buffalo
- Study site
- Joe DiMaggio
- Registry record
- NCT07048574 · updated
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- NextPhase Research Florida - Hollywood
- Registry record
- NCT07775300 · updated
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT06966401 · updated
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- AbbVie
- Study site
- CenExel Hollywood FL /ID# 273101
- Registry record
- NCT06696755 · updated
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT06911112 · updated
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- LB Pharmaceuticals Inc.
- Study site
- Cenexel Hollywood Florida
- Registry record
- NCT07494305 · updated
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- AbbVie
- Study site
- CenExel Hollywood FL /ID# 278200
- Registry record
- NCT07276997 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Hollywood, FL on ClinicalTrials.gov.
Schizophrenia studies recruiting in Hollywood
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
- Phase 3
- Ages 18 to 55
- All sexes
- Sponsor
- Minerva Neurosciences
- Study site
- Behavioral Clinical Research, Inc.
- Registry record
- NCT07565428 · updated
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Phase 3
- Ages 13 to 17
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- CenExel
- Registry record
- NCT07288567 · updated
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Phase 3
- Ages 5 to 17
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study site
- Research Centers of America - Hollywood - CenExel - PPDS
- Registry record
- NCT07424404 · updated
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study site
- Research Centers of America ( Hollywood )
- Registry record
- NCT07686263 · updated
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- MapLight Therapeutics
- Registry record
- NCT07459647 · updated
A Study of Brenipatide in Adult Participants With Schizophrenia
- Phase 2
- Ages 18 to 55
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- NextPhase Research Florida - Hollywood
- Registry record
- NCT07410507 · updated
NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT07105098 · updated
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT07114874 · updated
Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT07227818 · updated
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- Phase 1
- Ages 18 to 55
- All sexes
- Sponsor
- Leal Therapeutics, Inc
- Study sites
- Behavioral Clinical Research, Inc. · CenExel Hollywood FL
- Registry record
- NCT07734493 · updated
52-week Open Label Safety-Tolerability Study
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- LB Pharmaceuticals Inc.
- Study site
- CenExel
- Registry record
- NCT07369154 · updated
A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
- Phase 1
- Ages 18 to 55
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Research Centers of America ( Hollywood )
- Registry record
- NCT07061288 · updated
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT06963034 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Hollywood, FL on ClinicalTrials.gov.
Bipolar disorder studies recruiting in Hollywood
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Behavioral Clinical Research
- Registry record
- NCT06951711 · updated
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study sites
- Behavioral Clinical Research · Research Centers of America ( Hollywood )
- Registry record
- NCT06929273 · updated
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Research Centers of America ( Hollywood )
- Registry record
- NCT06951698 · updated
An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT07288320 · updated
Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Hollywood, FL on ClinicalTrials.gov.
Multiple sclerosis (MS) studies recruiting in Hollywood
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
- Phase 3
- Ages 40 to 70
- All sexes
- Sponsor
- Novartis Pharmaceuticals
- Study site
- Memorial Healthcare System
- Registry record
- NCT06846281 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Hollywood, FL on ClinicalTrials.gov.
Migraine studies recruiting in Hollywood
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Phase 4
- Ages 18 to 70
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Memorial Healthcare
- Registry record
- NCT06972056 · updated
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Study site
- Encore Medical Research /ID# 245682
- Registry record
- NCT05125302 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Hollywood, FL on ClinicalTrials.gov.
Ask about studies near Hollywood
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Florida
All Florida locations
225 studies recruiting across 72 cities.
Miami
82 studies recruiting.
Tampa
70 studies recruiting.
Orlando
57 studies recruiting.
Jacksonville
39 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections